Medsafe Logo
<% Dim q q = request.form("q") If len(q) > 0 Then Response.redirect "/searchResults.asp?q=" & q End if %>
Hide menus
Show menus

Publications

Published: September 2010

The use of varenicline (Champix) in NZ: Key findings from IMMP study

Prescriber Update 31(3): 22
September 2010

Dr Mira Harrison-Woolrych, Head, IMMP

Prescribers are reminded that the varenicline product information advises a 12 week course of treatment commencing with a starter pack and that failure to complete the course may have implications for the effectiveness of this smoking cessation treatment.1

A recently published study from the NZ Intensive Medicines Monitoring Programme (IMMP) on the use of varenicline (Champix) had the following key findings:2

References
  1. Pfizer Ltd. New Zealand datasheet for Champix. May 2012. Available at: www.medsafe.govt.nz/profs/Datasheet/c/Champixtab.pdf
  2. Harrison-Woolrych M and Ashton J. 2010. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand. Pharmacoepidemiology and Drug Safety 19: 1-5.

 

0 1 2 4 5 6 7 9 [ /